Immunovant, Inc. IMVT Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| -$505.61M-8.9% | -$464.2M+0.1% | -$464.69M-3.9% | -$447.3M-8.1% | -$413.84M-8.1% | ||
| $409K-3.1% | $422K+0.5% | $420K+4.0% | $404K+7.2% | $377K+13.6% | ||
| $55.72M-1.0% | $56.27M+1.9% | $55.21M+1.2% | $54.54M+10.2% | $49.49M+4.2% | ||
| -$407.31M+3.7% | -$422.89M+1.9% | -$430.95M-3.3% | -$417.09M-11.0% | -$375.87M-15.7% | ||
| $8K-96.0% | $201K-47.2% | $381K-34.0% | $577K-24.0% | $759K+7.2% | ||
| -$8K+96.0% | -$201K+47.2% | -$381K+34.0% | -$577K+24.0% | -$759K-7.2% | ||
| $595.76M-42.9% | $1.04B+117% | $480.59M+5.2% | $456.72M+0.5% | $454.49M+8,278% | ||
| —— | $619.84M+1,167% | $48.93M+25.8% | $38.91M-50.5% | $78.61M— | ||
| -$407.32M+3.7% | -$423.09M+1.9% | -$431.34M-3.3% | -$417.66M-10.9% | -$376.63M-15.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Immunovant, Inc. generate?
- Immunovant, Inc. (IMVT) generated -$407.3M in operating cash flow over the trailing twelve months.
- What is Immunovant, Inc.'s free cash flow?
- After $8.0K of capital expenditures, Immunovant, Inc.'s free cash flow was -$407.3M over the trailing twelve months, down 8.2% year over year.
- Where does Immunovant, Inc.'s cash flow data come from?
- Every line is extracted from Immunovant, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.